Sort by 'shares'
Myeloma with The MMRF
Towards the end of last year in 2013, MMRF rolled out three important cancer research initiatives - big data and genomic sequencing, open access by sharing research data, and empowering patients to find clinical trials that are best for them…
Post-Transplant Outcomes in High Risk Multiple Myeloma
Treatment of patients with myeloma has changed dramatically in the past years due to development of new agents and myeloma specific targets. Despite these advancements, long term benefits remains less clear in high-risk multiple myeloma patients. Myeloma is classified as…
Alzheimer’s or Dementia. What’s the Difference?
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However,…
PCOS & Eating Disorders – Managing the Nutritional & Psychological Aspects
Research indicates that the prevalence of #eatingdisorders such as #anorexianervosa, #bulimianervosa and other unspecified eating disorders is higher in women diagnosed with Polycystic Ovary Syndrome (PCOS) compared to that in the general population. Current treatment approaches for #PCOS emphasize the…
Myeloma ASH 2013 Review
Tune in to get interesting myeloma updates - 2013 ASH conference, from Myeloma Support Group leaders and myeloma advocates, Gary Petersen, Pat Killingsworth, Jack Aiello, and Cynthia Chmielewski.